Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial
Sebastian Stintzing, Pratyaksha Wirapati, Heinz‐Josef Lenz, Daniel Neureiter, Ludwig Fischer von Weikersthal, Thomas W. Decker and 17 more
- Rank
- 65 of 4,622
- Percentile
- top 1.5%
- Where
- Annals of Oncology, 2019
- Citations
- 197
From the 2019 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.